All medicines (including vaccines) are tested for safety and effectiveness before they are allowed to be used. Once they are in use, their safety continues to be monitored by the Medicines and Healthcare products Regulatory Agency (MHRA).
The RSV vaccine has passed strict safety standards for use in the UK and has been shown to be very safe. As with all vaccines, any reports of side effects are closely monitored and reviewed.
The RSV vaccination older adult programme is a year-round programme for individuals turning 75 years. During the first year there is a catch-up programme for those aged 75 to 79 years (until 31 August 2025). The table below shows which older adults are eligible for the RSV vaccine.
Age on 1 September 2024 |
When can the RSV vaccine be administered? |
Eligibility period |
74 |
On or after 75th birthday |
Until 80th birthday |
75 – 78 |
Between 1 September 2024 and 31 August 2025 |
Until 80th birthday |
79 |
Between 1 September 2024 and 31 August 2025 |
Until 31 August 2025 |
Frequently asked questions can be found on the Public Health Wales website, please click here.